--- title: Why enzymes are the backbone of successful mRNA in vitro transcription description: Read how enzymes are crucial to the success of mRNA in vitro transcription and learn tips for choosing the right enzymes to optimise performance. image: https://blog.biosearchtech.com/hubfs/Enzymes%20for%20IVT%20mRNA%20blog%20header.png --- [![LGC BTI logo](https://www.biosearchtech.com/Content/images/sourceimages/logo-bt.svg "LGC BTI logo")](https://www.biosearchtech.com/) ![Biosearch_Technologies_Logo_RGB_White_no tagline](https://blog.biosearchtech.com/hs-fs/hubfs/Biosearch_Technologies_Logo_RGB_White_no%20tagline.png?width=180&height=39&name=Biosearch_Technologies_Logo_RGB_White_no%20tagline.png)   [Blog](https://blog.biosearchtech.com) / Why enzymes are the backbone of successful mRNA in vitro transcription # Why enzymes are the backbone of successful mRNA in vitro transcription [Genomics](https://blog.biosearchtech.com/topic/genomics) | [Enzymes](https://blog.biosearchtech.com/topic/enzymes) | [mRNA therapeutics](https://blog.biosearchtech.com/topic/mrna-therapeutics) **Time to read:**   3 minute read Originally published : Tue, November 26, 2024 @ 10:14 PM ## *Updated : Friday, 31 January, 2025 @ 9:10 AM CT* Just as enzymes are the workhorses of our cells, they continue to play a vital role on a much larger scale in [manufacturing mRNA therapeutics](https://blog.biosearchtech.com/how-to-design-mrna-therapeutics-for-scalable-success). *In vitro* transcription has already enabled society to vaccinate the world against COVID-19 and there’s much more yet to come.  There are dozens of clinical trials testing mRNA vaccines in diseases from acute gastroenteritis to Zika. Delivering these new therapeutics on a mass scale requires specialist manufacturing processes far removed from the chemical synthesis of small molecule drugs.  *In vitro* transcription recreates the processes happening inside each of us just by using a few key enzymes. Then further specialist enzymes can also help with characterising and purifying the reaction products to ensure high quality. In this blog post we take a quick look at the steps to make this happen and the enzymes involved. ![Enzymes for IVT mRNA synthesis workflow steps-1](https://blog.biosearchtech.com/hs-fs/hubfs/Enzymes%20for%20IVT%20mRNA%20synthesis%20workflow%20steps-1.png?width=750&height=157&name=Enzymes%20for%20IVT%20mRNA%20synthesis%20workflow%20steps-1.png)![Enzymes for IVT mRNA synthesis workflow steps](https://blog.biosearchtech.com/hubfs/Enzymes%20for%20IVT%20mRNA%20synthesis%20workflow%20steps.png) Figure 1. An overview of steps involved in mRNA IVT. Precise workflows may vary and some steps, like capping and tailing, may be completed together during transcription.   #### Manufacturing the mRNA  **T7 RNA polymerase** is the most commonly used enzyme for *in vitro* transcription. The [NxGen T7 RNA Polymerase](https://shop.biosearchtech.com/molecular-biology-enzymes/polymerases/dna-and-rna-polymerases/nxgen-t7-rna-polymerase/p/30223-1) is a reliable and robust enzyme that recognises the T7 promoter and terminator sequences in the DNA template with high specificity. The transcription process takes only a few hours with a plentiful supply of nucleoside triphosphates.  Throughout the transcription process, it’s vital to prevent the mRNA product being degraded. An **RNase inhibitor**, like [RiboGuard™](https://shop.biosearchtech.com/pcr-instruments%2c-reagents-and-consumables/pcr-and-qpcr-reagents/rnase-inhibitors/riboguard-rnase-inhibitor/p/PCRAMP-014) protects against several common RNases. Riboguard doesn’t interfere with the enzymes used to analyse the RNA and is less prone to oxidation than older RNase inhibitors.   A poly(A) tail is a vital element of mRNA that protects it from nuclease degradation and![image017](https://blog.biosearchtech.com/hs-fs/hubfs/image017.png?width=265&height=155&name=image017.png) promotes protein translation. If the tail isn’t already encoded in the DNA template, it can be added post-transcriptionally with **poly(A) polymerase**. The [Poly(A) Polymerase Tailing Kit](https://shop.biosearchtech.com/molecular-biology-enzymes/polymerases/dna-and-rna-polymerases/poly%28a%29-polymerase-tailing-kit/p/PAP5104H) provides the enzyme and adenosine monophosphate residues to add a poly(A) tail to the 3′ end of any RNA.   The mRNA also requires a 5′ cap for effective translation *in vivo*. Although many developers use capping agents during transcription, it’s also possible to add the cap post-transcription using enzymes.   A variety of **capping enzymes** are available, which partially hydrolyse the triphosphate group, create a 5′-5′ linkage to a guanidine and methylate the guanidine at the N7 position. This can then be converted to the eukaryotic Cap-1 structure with a **2′‐O‐methyltransferase** enzyme.  --- **To learn about generating the DNA template and getting the best performance for transcription, download our in-depth **[**ebook**](https://info.biosearchtech.com/enzymes_for_ivt_mrna-synthesis_ebook)**.** --- #### Purification and characterisation After transcribing the mRNA and adding the necessary elements, it is essential to purify and characterise the reaction product. This helps to ensure that it meets clinical standards and matches the desired structure.  The DNA transcription template needs to be removed, which can be achieved with [**DNase I**](https://shop.biosearchtech.com/molecular-biology-enzymes/nucleases/dna-nucleases/rnase-free-dnase-i/p/D9905K). This enzyme degrades both double and single-stranded DNA, leaving just short oligonucleotides and mononucleotides that can be easily separated with a column.  Uncapped RNA molecules can be removed from the mix using two enzymes together. [**RNA 5′ Polyphosphatase**](https://shop.biosearchtech.com/molecular-biology-enzymes/dna-and-rna-modifying-enzymes/kinases-and-phosphatases/rna-5%27-polyphosphatase/p/RP8092H) removes two phosphate groups at the 5′ end of uncapped RNA transcripts, leaving one remaining 5′ phosphate group. This leaves them unprotected against degradation by [**Terminator™ 5′-Phosphate-Dependent Exonuclease**](https://shop.biosearchtech.com/molecular-biology-enzymes/nucleases/rna-nucleases/terminator-5%27-phosphate-dependent-exonuclease/p/TER51020), a 5′→3′ exonuclease.  To characterise the purified mRNA product, it can be broken down into fragments and assessed using LC-MS. One approach for this is to use **RNase H**, which degrades RNA in a DNA:RNA hybrid. Developers can design a cleavage probe that hybridises with the mRNA at the required cleavage site to generate the desired fragment. [Hybridase](https://shop.biosearchtech.com/molecular-biology-enzymes/nucleases/rna-nucleases/hybridase-thermostable-rnase-h/p/PCRAMP-022) is a high-performance RNase H that maintains activity as high as 95 °C and will not digest free RNA or DNA.  Another important enzyme is [**RNase A**](https://shop.biosearchtech.com/molecular-biology-enzymes/nucleases/rna-nucleases/rnase-a/p/MRNA092), which degrades single-stranded RNA at C and U residues. This digests most of the mRNA, leaving the poly-A tail ready for characterisation.  To make it easier to analyse mRNA fragments with LC-MS, [**T4 Polynucleotide Kinase (PNK)**](https://shop.biosearchtech.com/molecular-biology-enzymes/dna-and-rna-modifying-enzymes/kinases-and-phosphatases/t4-polynucleotide-kinase%2c-cloned/p/NXGENZ-005) can standardise the phosphate groups at the termini. It dephosphorylates 3′ ends and introduces a monophosphate group to 5′ hydroxyl groups.  --- **Our **[**ebook**](https://info.biosearchtech.com/enzymes_for_ivt_mrna-synthesis_ebook)** ‘Enzymes for mRNA *****in vitro***** transcription’ contains full details about using enzymes for purification and characterisation.**  --- #### Circular RNA A similar process is necessary for manufacturing [circular RNA](https://blog.biosearchtech.com/why-circular-rna-could-be-the-next-revolution-in-rna-therapeutics) molecules. However, there is no need for capping and tailing – instead enzymes can be used for ligating the 5'-phosphate and 3'-hydroxyl ends. For example, [**T4 DNA ligase**](https://shop.biosearchtech.com/molecular-biology-enzymes/dna-and-rna-modifying-enzymes/dna-and-rna-ligases/nxgen-t4-dna-ligase/p/NXGENZ-001) can join two RNA ends and circularise mRNA. T4 ![circular_RNA_design](https://blog.biosearchtech.com/hs-fs/hubfs/circular_RNA_design.png?width=255&height=255&name=circular_RNA_design.png)DNA ligase only acts on double-stranded regions, so a complementary oligo is needed as a splint to bring the ends together in a double helix at the ligation site.   However, there are many other circularisation methods, which are further detailed in our [ebook](https://info.biosearchtech.com/enzymes_for_ivt_mrna-synthesis_ebook).  After circularisation, the precursor linear RNA can be removed using [**RNase R**](https://shop.biosearchtech.com/molecular-biology-enzymes/nucleases/rna-nucleases/ribonuclease-r-%28rnase-r%29/p/NXGENZ-010), a 3′ to 5′ exoribonuclease that digests most linear RNAs. RNase R leaves the circRNA untouched, helping to purify the product and avoid potential safety risks from impurities.     #### Choosing the right enzymes Partnering with preferred suppliers that guarantee the products are produced in facilities certified to ISO-13485 quality system standards can ensure that enzymes for IVT are high-quality and reliable. Potential consequences for using sub-optimal raw materials include:  - ![organic_image_11](https://blog.biosearchtech.com/hs-fs/hubfs/organic_image_11.png?width=334&height=251&name=organic_image_11.png)Enhanced risk of workflow delays from lot-to-lot variation in enzyme performance - Additional purification increases production costs  - Potential for nonconformance and supplier qualification issues during regulatory review by Competent Authorities  - Difficulty scaling production for commercialisation  - Wasted time and resources on repeat work due to variability in raw material performance  When developing and scaling IVT manufacturing, it might become important to customise the formulation of IVT enzymes. Popular enzyme customisations for IVT mRNA synthesis include:  - Different concentrations  - Triton free or glycerol free  - Custom QC based on your requirements  - Batch reservation  - Lot retention  - Custom storage or reaction buffers  - Bulk dispense  --- | [![enzymes_IVT_mRNA_ebook_organic_x2](https://blog.biosearchtech.com/hs-fs/hubfs/enzymes_IVT_mRNA_ebook_organic_x2.png?width=288&height=254&name=enzymes_IVT_mRNA_ebook_organic_x2.png)](https://info.biosearchtech.com/enzymes_for_ivt_mrna-synthesis_ebook) | For more information about enzymes for mRNA in vitro transcription, check out our ebook full of tips and insights to optimise your enzyme performance.  [Download ebook](https://info.biosearchtech.com/enzymes_for_ivt_mrna-synthesis_ebook) | | --- | --- |   - [**](http://www.facebook.com/sharer.php?u=https://blog.biosearchtech.com/enzymes-as-the-backbone-of-success-in-mrna-ivt) - [** ](http://www.linkedin.com/shareArticle?url=https://blog.biosearchtech.com/enzymes-as-the-backbone-of-success-in-mrna-ivt&title=Why%20enzymes%20are%20the%20backbone%20of%20successful%20mRNA%20in%20vitro%20transcription) - [** ](http://twitter.com/intent/tweet?text=Why%20enzymes%20are%20the%20backbone%20of%20successful%20mRNA%20in%20vitro%20transcription&url=https://blog.biosearchtech.com/enzymes-as-the-backbone-of-success-in-mrna-ivt) - [** ](mailto:?subject=I%20wanted%20you%20to%20see%20this%20post&body=Check%20out%20this%20post%20.) #### Like what you see? Share with a friend or comment below. [** ](https://www.facebook.com/sharer/sharer.php?u=https://blog.biosearchtech.com/enzymes-as-the-backbone-of-success-in-mrna-ivt) [** ](https://www.linkedin.com/shareArticle?mini=true&url=https://blog.biosearchtech.com/enzymes-as-the-backbone-of-success-in-mrna-ivt) [** ](https://twitter.com/intent/tweet?url=https://blog.biosearchtech.com/enzymes-as-the-backbone-of-success-in-mrna-ivt&text=Why%20enzymes%20are%20the%20backbone%20of%20successful%20mRNA%20in%20vitro%20transcription) [** ](mailto:?subject=I%20wanted%20you%20to%20see%20this%20post&body=Check%20out%20this%20post%20.) ## Subscribe to our blog ## BiosearchTech Blog alerts Don’t forget to subscribe to the latest scientific content curated * by* scientists * for *scientists. You’ll receive an email twice a month or less. ### Subscribe to our blog ### About LGC, Biosearch Technologies LGC, Biosearch Technologies is the complete Genomics portfolio from LGC. Providing genomic analysis tools, instrumentation and services to the genomic scientific discovery sector worldwide, with focus on across ag bio, pharma and molecular diagnostics. Visit our home page to [view our products and services](http://www.biosearchtech.com). ### Posts by category - [Agrigenomics (37)](https://blog.biosearchtech.com/topic/agrigenomics) - [CPG (2)](https://blog.biosearchtech.com/topic/cpg) - [Disease detection (14)](https://blog.biosearchtech.com/topic/disease-detection) - [Enzymes (3)](https://blog.biosearchtech.com/topic/enzymes) - [General science (90)](https://blog.biosearchtech.com/topic/general-science) - [Genomics (48)](https://blog.biosearchtech.com/topic/genomics) - [KASP (4)](https://blog.biosearchtech.com/topic/kasp) - [Molecular diagnostics (53)](https://blog.biosearchtech.com/topic/molecular-diagnostics) - [mRNA therapeutics (2)](https://blog.biosearchtech.com/topic/mrna-therapeutics) - [New and Featured (2)](https://blog.biosearchtech.com/topic/new-and-featured) - [Next generation sequencing (NGS) (16)](https://blog.biosearchtech.com/topic/next-generation-sequencing-ngs) - [NGS-based genotyping (19)](https://blog.biosearchtech.com/topic/ngs-based-genotyping) - [Nucleic acid extraction (11)](https://blog.biosearchtech.com/topic/nucleic-acid-extraction) - [Nucleic acid therapeutics (15)](https://blog.biosearchtech.com/topic/nucleic-acid-therapeutics) - [Oligo synthesis and modifications (41)](https://blog.biosearchtech.com/topic/oligo-synthesis-and-modifications) - [oligos probes and primers (4)](https://blog.biosearchtech.com/topic/oligos-probes-and-primers) - [PCR-based genotyping (21)](https://blog.biosearchtech.com/topic/pcr-based-genotyping) - [qPCR (61)](https://blog.biosearchtech.com/topic/qpcr) - [RNA FISH (22)](https://blog.biosearchtech.com/topic/rna-fish) - [SARS-CoV-2 (28)](https://blog.biosearchtech.com/topic/sars-cov-2) - [Targeted GBS (4)](https://blog.biosearchtech.com/topic/targeted-gbs) ### Posts by popularity ### Follow @BiosearchTech on Twitter [Tweets by @BiosearchTech](https://twitter.com/BiosearchTech) ### Become a Fan on Facebook! ### Visit our website [biosearchtech.com](https://www.biosearchtech.com/) ### Contact us - [** Contact us ](https://www.biosearchtech.com/about-us/locations) ### Connect with us - [![twitter](https://blog.biosearchtech.com/hubfs/blog2020/twitter-1.png)Twitter ](https://twitter.com/LGCBiosearch) - [** Facebook ](https://www.facebook.com/LGCBiosearch) - [** Youtube ](https://www.youtube.com/user/lgcgroupvideo) - [** LinkedIn ](https://www.linkedin.com/company/lgc-biosearch-technologies) Copyright © 2023 LGC, Biosearch Technologies  ### About Us - [About LGC Biosearch Technologies](https://www.biosearchtech.com/about-us/inside-lgc-biosearch) - [Careers](https://www.biosearchtech.com/our-company/careers) - [Shop](https://www.biosearchtech.com/about-us/distributors) ### Stay in Touch - [Contact us](https://www.biosearchtech.com/about-us/contact-us) - [Join our mailing list](https://www.biosearchtech.com/) - - [** ](https://www.facebook.com/LGCBiosearch) - [** ](https://www.youtube.com/user/lgcgroupvideo) - [** ](https://www.linkedin.com/company/lgc-biosearch-technologies) Copyright © 2024 LGC Biosearch Technologies  ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Biosearch Technologies", "url" : "https://blog.biosearchtech.com/author/biosearch-technologies" }, "dateModified" : "2025-03-05T17:49:02.716Z", "datePublished" : "2025-01-31T15:15:00.000Z", "headline" : "Why enzymes are the backbone of successful mRNA in vitro transcription", "image" : [ "https://blog.biosearchtech.com/hubfs/Enzymes%20for%20IVT%20mRNA%20blog%20header.png" ], "mainEntityOfPage" : { "@id" : "https://blog.biosearchtech.com/enzymes-as-the-backbone-of-success-in-mrna-ivt", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.biosearchtech.com/hubfs/LGC_D&G_Logos_RGB_LGC_D&G_Primary.png" }, "name" : "Biosearch Technologies" } } ```